Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages. uri icon

Overview

publication date

  • January 23, 2015

Research

keywords

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Cytophagocytosis
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Macrophages

Identity

PubMed Central ID

  • PMC4380736

Scopus Document Identifier

  • 84926290880

Digital Object Identifier (DOI)

  • 10.3324/haematol.2014.119669

PubMed ID

  • 25616578

Additional Document Info

volume

  • 100

issue

  • 4